CapeHaven is a biotech venture builder that focuses on developing therapeutics into financeable businesses.
CapeHaven has raised $10.0M in total funding. The most recent round was Undisclosed. The last funding was announced in May 2026.
CapeHaven is headquartered in New Haven, United States.
CapeHaven is a biotech venture builder that focuses on developing therapeutics into financeable businesses.
CapeHaven is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CapeHaven — Funding & Investors." VCBacked, May 14, 2026, https://www.vcbacked.co/company/capehaven. Accessed October 2, 2026.
VCBacked. (2026). CapeHaven — Funding & Investors. Retrieved October 2, 2026, from https://www.vcbacked.co/company/capehaven
{{cite web |title=CapeHaven — Funding & Investors |url=https://www.vcbacked.co/company/capehaven |website=VCBacked |access-date=October 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated